Literature DB >> 20975037

Cancer risks after radiation exposure in middle age.

Igor Shuryak1, Rainer K Sachs, David J Brenner.   

Abstract

BACKGROUND: Epidemiological data show that radiation exposure during childhood is associated with larger cancer risks compared with exposure at older ages. For exposures in adulthood, however, the relative risks of radiation-induced cancer in Japanese atomic bomb survivors generally do not decrease monotonically with increasing age of adult exposure. These observations are inconsistent with most standard models of radiation-induced cancer, which predict that relative risks decrease monotonically with increasing age at exposure, at all ages.
METHODS: We analyzed observed cancer risk patterns as a function of age at exposure in Japanese atomic bomb survivors by using a biologically based quantitative model of radiation carcinogenesis that incorporates both radiation induction of premalignant cells (initiation) and radiation-induced promotion of premalignant damage. This approach emphasizes the kinetics of radiation-induced initiation and promotion, and tracks the yields of premalignant cells before, during, shortly after, and long after radiation exposure.
RESULTS: Radiation risks after exposure in younger individuals are dominated by initiation processes, whereas radiation risks after exposure at later ages are more influenced by promotion of preexisting premalignant cells. Thus, the cancer site-dependent balance between initiation and promotion determines the dependence of cancer risk on age at radiation exposure. For example, in terms of radiation induction of premalignant cells, a quantitative measure of the relative contribution of initiation vs promotion is 10-fold larger for breast cancer than for lung cancer. Reflecting this difference, radiation-induced breast cancer risks decrease with age at exposure at all ages, whereas radiation-induced lung cancer risks do not.
CONCLUSION: For radiation exposure in middle age, most radiation-induced cancer risks do not, as often assumed, decrease with increasing age at exposure. This observation suggests that promotional processes in radiation carcinogenesis become increasingly important as the age at exposure increases. Radiation-induced cancer risks after exposure in middle age may be up to twice as high as previously estimated, which could have implications for occupational exposure and radiological imaging.

Entities:  

Mesh:

Year:  2010        PMID: 20975037      PMCID: PMC2970575          DOI: 10.1093/jnci/djq346

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  55 in total

1.  Stochastic modelling of colon cancer: is there a role for genomic instability?

Authors:  Mark P Little; Guangquan Li
Journal:  Carcinogenesis       Date:  2006-09-14       Impact factor: 4.944

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2009-05-29       Impact factor: 1.925

4.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-05       Impact factor: 1.925

Review 5.  The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.

Authors:  N Waugh; C Black; S Walker; L McIntyre; E Cummins; G Hillis
Journal:  Health Technol Assess       Date:  2006-10       Impact factor: 4.014

Review 6.  Biology of aging and cancer.

Authors:  Vladimir N Anisimov
Journal:  Cancer Control       Date:  2007-01       Impact factor: 3.302

7.  CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials.

Authors:  David S Gierada; Kavita Garg; Hrudaya Nath; Diane C Strollo; Richard M Fagerstrom; Melissa B Ford
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

8.  Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors.

Authors:  Mark P Little
Journal:  Radiat Environ Biophys       Date:  2009-05-27       Impact factor: 1.925

9.  Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer.

Authors:  David J Brenner
Journal:  Radiology       Date:  2004-05       Impact factor: 11.105

Review 10.  CT screening for lung cancer: update 2007.

Authors:  Claudia I Henschke; David F Yankelevitz
Journal:  Oncologist       Date:  2008-01
View more
  52 in total

1.  Prevalence of Protective Shielding Utilization for Radiation Dose Reduction in Adult Patients Undergoing Body Scanning Using Computed Tomography.

Authors:  Shoaib Safiullah; Roshan Patel; Brittany Uribe; Kyle Spradling; Chandana Lall; Lishi Zhang; Zhamshid Okhunov; Ralph V Clayman; Jaime Landman
Journal:  J Endourol       Date:  2017-08-14       Impact factor: 2.942

2.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

3.  Prioritizing examination-centered over patient-centered dose reduction: a hazard of institutional "benchmarking".

Authors:  Jonathan D Eisenberg; Michael E Gilmore; Mannudeep K Kalra; Chung Yin Kong; Pari V Pandharipande
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

4.  High-pitch CT, decreasing need for sedation and its potential side effects: some practical considerations and future directions.

Authors:  Sjirk J Westra
Journal:  Pediatr Radiol       Date:  2018-12-10

5.  Lung cancer screening with ultra-low dose CT using full iterative reconstruction.

Authors:  Masayo Fujita; Toru Higaki; Yoshikazu Awaya; Toshio Nakanishi; Yuko Nakamura; Fuminari Tatsugami; Yasutaka Baba; Makoto Iida; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2017-02-14       Impact factor: 2.374

6.  Emergency assessment of patients with acute abdominal pain using low-dose CT with iterative reconstruction: a comparative study.

Authors:  Pierre-Alexandre Poletti; Minerva Becker; Christoph D Becker; Alice Halfon Poletti; Olivier T Rutschmann; Habib Zaidi; Thomas Perneger; Alexandra Platon
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

Review 7.  Protecting sensitive patient groups from imaging using ionizing radiation: effects during pregnancy, in fetal life and childhood.

Authors:  Paolo Tomà; Alessandra Bartoloni; Sergio Salerno; Claudio Granata; Vittorio Cannatà; Andrea Magistrelli; Owen J Arthurs
Journal:  Radiol Med       Date:  2019-04-04       Impact factor: 3.469

8.  Cancer-prone mice expressing the Ki-rasG12C gene show increased lung carcinogenesis after CT screening exposures.

Authors:  Michael T Munley; Joseph E Moore; Matthew C Walb; Scott P Isom; John D Olson; J Gregory Zora; Nancy D Kock; Kenneth T Wheeler; Mark Steven Miller
Journal:  Radiat Res       Date:  2011-09-30       Impact factor: 2.841

9.  Topogram-based automated selection of the tube potential and current in thoraco-abdominal trauma CT - a comparison to fixed kV with mAs modulation alone.

Authors:  Claudia Frellesen; Wenzel Stock; J Matthias Kerl; Thomas Lehnert; Julian L Wichmann; Christoph Nau; Emanuel Geiger; Sebastian Wutzler; Martin Beeres; Boris Schulz; Boris Bodelle; Hanns Ackermann; Thomas J Vogl; Ralf W Bauer
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

10.  Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.

Authors:  Lindsey C Wu; Ruth A Kleinerman; Rochelle E Curtis; Sharon A Savage; Amy Berrington de González
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-10       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.